A Hindi-language post from Canwinn Aarogya Dham tells people on Ozempic, Mounjaro or Wegovy to get a baseline eye exam, citing possible risks to vision.
Recap by typeshit. Post by @canwinn_aarogya_dham on Instagram.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
She points to a small study that found no detectable semaglutide in breast milk of nursing mothers on the injection, while saying more research is still needed.
Egyptian researchers followed 48 adults with type 1 diabetes and obesity who were using tirzepatide on their own, and presented the work at a meeting in Milan.
Loading…